Human TSHR extracellular fusion protein and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV
- Publication Date
- 2010-12-29
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology and relates to the recombination and bioengineering preparation of human TSH receptors, in particular to a human TSHR extracellular fusion protein and a preparation method thereof. Background technique
[0002] Autoimmune thyroid disease (AITD) is an organ-specific disease, including Graves' disease (GD), Hashimoto's thyroiditis (Hashimoto's thyroiditis, HT) and idiopathic myxedema (Primary myxedema, PM), its incidence rate accounts for the first place in endocrine system diseases. Thyrotropin receptor (TSHR) is the main antigen that induces AITD.
[0003] The molecular weight of human TSHR is 84.5KD, and it reaches 100KD after glycosylation, which is closely related to the pathogenesis of AITD. Human TSHR mainly exists on the thyroid cell membrane and belongs to one of the members of the guanine nucleotide regulatory protein (G protein) coupled receptor superfamily; it consists of three parts: the ...